Dried-blood sampling for epstein-barr virus immunoglobulin G (IgG) and IgA serology in nasopharyngeal carcinoma screening

Journal of Clinical Microbiology

Volumn 46, Issue 4, 2008, Pages 1374-1380

  Fachiroh, J ^a   Prasetyanti, P R ^a   Paramita, D K ^a   Prasetyawati, A T ^a   Anggrahini, D W ^a   Haryana, S M ^a   Middeldorp, J M ^a,b  

^a GADJAH MADA UNIVERSITY   (Indonesia)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; CAPSID PROTEIN; EBV ENCODED NUCLEAR ANTIGEN 1; EBV-ENCODED NUCLEAR ANTIGEN 1; EPSTEIN BARR VIRAL CAPSID ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN-BARR VIRAL CAPSID ANTIGEN; PEPTIDE; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER SCREENING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN TISSUE; MALE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROLOGY; BLOOD; CARCINOMA; EVALUATION; IMMUNOLOGY; MASS SCREENING; METHODOLOGY; NASOPHARYNX TUMOR; SYNTHESIS; VIROLOGY; VIRUS INFECTION;

HUMAN HERPESVIRUS 4; MIRIDAE;

ANTIGENS, VIRAL; BLOOD SPECIMEN COLLECTION; CAPSID PROTEINS; CARCINOMA; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MASS SCREENING; NASOPHARYNGEAL NEOPLASMS; PEPTIDES; SENSITIVITY AND SPECIFICITY;

EID: 42449138332     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01368-07     Document Type: Article

References (50)

1. Ayele, W., et al. 2007. Use of dried spots of whole blood, plasma, and mother's milk collected on filter paper for measurement of human immunodeficiency virus type 1 burden. J. Clin. Microbiol. 45:891-896.
2. Beck, I. A., et al. 2001. Simple, sensitive, and specific detection of human immunodeficiency virus type 1 subtype B DNA in dried blood samples for diagnosis in infants in the field. J. Clin. Microbiol. 39:29-33.
3. Behets, F., et al. 1992. Stability of human immunodeficiency virus type 1 antibodies in whole blood dried on filter paper and stored under various tropical conditions in Kinshasa, Zaire. J. Clin. Microbiol. 30:1179-1182.
4. Brink, A. A., et al. 1997. Multiprimed cDNA synthesis followed by PCR is the most suitable method for Epstein-Barr virus transcript analysis in small lymphoma biopsies. Mol. Cell. Probes 11:39-47.
5. Bussen, P., et al. 2004. EBV-associated nasopharyngeal carcinomas: from epidemiology to virus-targeting strategies. Trends Microbiol. 12:356-360.
6. Chace, D., et al. 1999. Validation of accuracy-based amino acid reference materials in dried-blood spots by tandem mass spectrophotometry for newborn screening assays. Clin. Chem. 45:1269-1277.
7. Chen, M. R., J. M. Middeldorp, and S. D. Hayward. 1993. Separation of the complex DNA binding domain of EBNA-1 into DNA recognition and dimerization subdomains of novel structure. J. Virol. 67:4875-4885.
8. Chien, Y. C., et al. 2001. Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N. Engl. J. Med. 345: 1877-1882.
9. Croom, H. A., et al. 2006. Commercial enzyme immunoassay adapted for the detection of antibodies to hepatitis C virus in dried blood spots. J. Clin. Virol. 36:68-71.
10. Crowther, J. R. 2001. The ELISA guidebook. 149:1-413.
11. Dardari, R., et al. 2001. Antibody responses to recombinant Epstein-Barr virus antigens in nasopharyngeal carcinoma patients: complementary test of ZEBRA protein and early antigens p54 and p138. J. Clin. Microbiol. 39: 3164-3170.
12. El Mubarak, H. S., et al. 2004. Surveillance of measles in the Sudan using filter paper blood samples. J. Med. Virol. 73:624-630.
13. Fachiroh, J., et al. 2004. Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: a comparison of Indonesian, Chinese, and European subjects. J. Infect. Dis. 190:53-62.
14. Fachiroh, J., et al. 2006. Single-assay combination of Epstein-Barr virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening. J. Clin. Microbiol. 44:1459-1467.
15. Guthrie, R., and A. Susi. 1963. A simple method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 32:338-342.
16. Gwinn, M., et al. 1991. Prevalence of HIV infection in childbearing women in the United States. Surveillance using newborn blood samples. JAMA 265:1704-1708.
17. Handali, S., et al. 2007. A simple method for collecting measured whole blood with quantitative recovery of antibody activities for serological surveys. J. Immunol. Methods 320:164-171.
18. Hannon, W. H., et al. 1989. A quality assurance program for human immunodeficiency virus seropositivity screening of dried-blood spot specimens. Infect. Control Hosp. Epidemiol. 10:8-13.
19. Henderson, L. O., et al. 1997. An evaluation of the use of dried blood spots from newborn screening for monitoring the prevalence of cocaine use among childbearing women. Biochem. Mol. Med. 61:143-151.
20. Henle, G., and W. Henle. 1976. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int. J. Cancer 17:1-7.
21. Hogrefe, W. R., C. Ernst, and X. Su. 2002. Efficiency of reconstitution of immunoglobulin G from blood specimens dried on filter paper and utility in herpes simplex virus type-specific serology screening. Clin. Diagn. Lab. Immunol. 9:1338-1342.
22. Ji, M. F., et al. 2007. Sustained elevation of Epstein-Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma. Br. J. Cancer 96:623-630.
23. Karray, H., et al. 2005. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia. J. Med. Virol. 75:593-602.
24. Li, C.-C., et al. 2004. Persistence of human immunodeficiency virus type 1 subtype B DNA in dried-blood samples on FTA filter paper. J. Clin. Microbiol. 42:3847-3849.
25. McDade, T. W., et al. 2000. Epstein-Barr virus antibodies in whole blood spots: a minimally invasive method for assessing an aspect of cell-mediated immunity. Psychosom. Med. 62:560-567.
26. Mei, J., et al. 2001. Use of filter paper for the collection and analysis of human whole blood specimens. J. Nutr. 131:S1631-S1636.
27. Mercader, S., D. Featherstone, and W. J. Bellini. 2006. Comparison of available methods to elute serum from dried blood spot samples for measles serology. J. Virol. Methods 137:140-149.
28. Middeldorp, J. October 1999. Epstein-Barr virus peptides and antibodies against these peptides. U.S. patent 5,965,353.
29. Middeldorp, J. M., and P. Herbrink. 1988. Epstein-Barr virus specific marker molecules for early diagnosis of infectious mononucleosis. J. Virol. Methods 21:133-146.
30. Middeldorp, J. M., and R. H. Meloen. 1988. Epitope-mapping on the Epstein-Barr virus major capsid protein using systematic synthesis of overlapping oligopeptides. J. Virol. Methods 21:147-159.
31. Motulsky, H. 2003. Prism 4 statistics guide - statistical analysis for laboratory and clinical researchers. GraphPad Software Inc., San Diego, CA.
32. National Committee for Clinical Laboratory Standards. 1997. Blood collection on filter paper for neonatal screening programs, 3rd ed. Approved standard A4A3. National Committee for Clinical Laboratory Standards, Wayne, PA.
33. Neto, E. C., et al. 2004. Newborn screening for congenital infectious diseases. Emerg Infect. Dis. 10:1068-1073.
34. Ng, M. H., et al. 2006. Epstein-Barr virus serology in early detection and screening of nasopharyngeal carcinoma. Ai Zheng 25:250-256.
35. Ng, W. T., et al. 2005. Screening for family members of patients with nasopharyngeal carcinoma. Int. J. Cancer 113:998-1001.
36. Old, L. J., et al. 1966. Precipitating antibody in human serum to an antigen present in cultured Burkitt's lymphoma cells. Proc. Natl. Acad. Sci. USA 56:1699-1704.
37. Parker, S. P., and W. D. Cubitt. 1999. The use of the dried blood spot sample in epidemiological studies. J. Clin. Pathol. 52:633-639.
38. Patchen, L. C., et al. 1983. Analysis of filter-paper-absorbed, finger-stick blood samples for chloroquinone and its major metabolite using high-performance liquid chromatography with fluorescence detection. J. Chromatogr. 278:81-89.
39. Riddell, M. A., et al. 2003. Dried venous blood samples for the detection and quantification of measles IgG using a commercial enzyme immunoassay. Bull. W. H. O. 81:701-707.
40. Shao, J. Y., et al. 2004. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma. Cancer 100: 1162-1170.
41. Soeripto. 1997. Epidemiology of nasopharyngeal carcinoma. Berita Kedokteran Masyarakat. XIII:207-211.
42. Stevens, S. J., et al. 2006. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA. Int. J. Cancer 119:608-614.
43. Stevens, S. J., et al. 2006. Epstein-Barr virus (EBV) serology for predicting distant metastases in a white juvenile patient with nasopharyngeal carcinom a and no clinical response to EBV lytic induction therapy. Head Neck 28:1040-1045.
44. Stevens, S. J. C., et al. 2005. Diagnostic value of measuring Epstein-Barr virus (EBV) DNA load and carcinoma-specific viral mRNA in relation to anti-EBV immunoglobulin A (IgA) and IgG antibody levels in blood of nasopharyngeal carcinoma patients from Indonesia. J. Clin. Microbiol. 43: 3066-3073.
45. Tanner, S., and T. McDade. 2007. Enzyme immunoassay for total immunoglobulin E in dried blood spots. Am. J. Hum. Biol. 19:440-442.
46. Therrell, B., et al. 1996. Guidelines for retention, storage and use of residual dried blood spot samples after newborn screening analysis: statement of the council of regional networks for genetic services. Biochem. Mol. Med. 57: 116-124.
47. van Grunsven, W. M., W. J. Spaan, and J. M. Middeldorp. 1994. Localization and diagnostic application of immunodominant domains of the BFRF3-encoded Epstein-Barr virus capsid protein. J. Infect. Dis. 170:13-19.
48. Yu, M. C., and J. M. Yuan. 2002. Epidemiology of nasopharyngeal carcinoma. Semin. Cancer Biol. 12:421-429.
49. Zeng, Y., et al. 1982. Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City, China. Int. J. Cancer 29:139-141.
50. Zeng, Y., et al. 1985. Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA/VCA antibody-positive persons in Wuzhou City, China. Int. J. Cancer 36:545-547.